Target intelligence / Profile preview

Bifidobacterium carbohydrate transporters and metabolic enzymes

Molecular classification
Enzyme, Transporter
01

Overview

Bifidobacterium carbohydrate transporters and metabolic enzymes represent a complex suite of proteins responsible for the degradation and utilization of complex glycans in the human gut (Pokusaeva et al., 2011, PubMed: 21415361). These bacteria utilize specialized ATP-binding cassette (ABC) transporters and phosphotransferase systems (PTS) to internalize various oligosaccharides, which are then processed by a diverse array of glycosyl hydrolases, such as beta-galactosidases and alpha-glucosidases (O'Callaghan & van Sinderen, 2016, PubMed: 27303377). A hallmark of this metabolism is the "bifid shunt," centered on the enzyme fructose-6-phosphate phosphoketolase, which efficiently converts hexoses into acetate and lactate (Turroni et al., 2018, PubMed: 29445130). By fermenting non-digestible dietary fibers and human milk oligosaccharides, these enzymes play a crucial role in maintaining gut homeostasis and supporting the development of the infant immune system (Sela et al., 2008, PubMed: 19047636). While not traditional drug targets for inhibition, they are primary targets for prebiotic interventions aimed at selectively increasing Bifidobacterium populations to treat conditions like inflammatory bowel disease and metabolic syndrome (Gibson et al., 2017, PubMed: 28611480). Therapeutic strategies focus on providing specific carbohydrate substrates that match the enzymatic repertoire of beneficial Bifidobacterium strains to promote the production of health-promoting short-chain fatty acids (Rivière et al., 2016, PubMed: 27375568). This metabolic activity also contributes to the "barrier effect," preventing the colonization of the gut by pathogenic microorganisms (Fukuda et al., 2011, PubMed: 21270894).

Other names
Bifidobacterial glycan utilization systemBifid shunt enzymesBifidobacterium carbohydrate metabolism pathwayBifidobacterial glycosyl hydrolases
02

Mechanism of action

Selective fermentation of prebiotic substrates to promote beneficial bacterial growth and produce health-promoting short-chain fatty acids (SCFAs)

03

Biological functions

Carbohydrate metabolismShort-chain fatty acid productionGut microbiota modulationImmune system modulationEnergy homeostasis
04

Disease associations

Inflammatory bowel diseaseObesityType 2 diabetesColorectal cancerNeonatal necrotizing enterocolitisAtopic dermatitis
05

Safety considerations

Gastrointestinal side effects (flatulence, bloating, abdominal pain)Potential for D-lactic acidosis in patients with short bowel syndromeRisk of opportunistic infection/bacteremia in severely immunocompromised patients
06

Interacting drugs

Inulin

5 more in the full profile.

07

Biomarkers

Bifidobacterium abundanceFecal acetate levelsFecal lactate levelsFructose-6-phosphate phosphoketolase activity

Beyond the preview

Go deeper on Bifidobacterium carbohydrate transporters and metabolic enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bifidobacterium carbohydrate transporters and metabolic enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call